latanoprost + bimatoprost

This refers to the comparative clinical evaluation of latanoprost and bimatoprost, two established prostaglandin analogs, for the treatment of chronic angle-closure glaucoma (CACG). The study, conducted by the Singapore National Eye Centre, was a randomized, observer-masked, crossover trial (NCT00149110) designed to assess the intraocular pressure (IOP) reducing effects of these medications. Latanoprost (Xalatan) is a prostaglandin F2-alpha analog that targets the FP prostanoid receptor to increase uveoscleral outflow. Bimatoprost (Lumigan) is a synthetic prostamide analog that increases aqueous humor outflow through both the uveoscleral and trabecular meshwork pathways. Both drugs are small molecules administered as ophthalmic solutions and are widely used to manage various forms of glaucoma and ocular hypertension.

Brand names

XalatanLumigan

Other names

latanoprost 0.005%bimatoprost 0.03%latanoprost-bimatoprost-Singapore National Eye Centre-chronic angle-closure glaucoma